Improving Protein Capture for Transgenic Drug Processing

Sellick,Ian;

Improving Protein Capture for Transgenic Drug Processing

November 2, 2003

By Ian Sellick

News

Article

Pharmaceutical TechnologyPharmaceutical Technology-11-02-2003

Volume 27

Issue 11

One of the greatest challenges facing biopharmaceutical manufacturers has been the primary recovery of recombinant materials from transgenic sources. As an alternative to existing methods, vibrating membrane technology, which is widely used in food and beverage processing, recently has been adapted to biopharmaceutical applications involving transgenic biosolutions.

External Link - article-75175.pdf

Articles in this issue

FDA Will Drive Changes for Contract Business

In the Spotlight--December

Novemember 2003

FDA Seeks Risk-Based Inspection Program

Routine Sample Size for a Retest Procedure

November 2003

Aseptic Processing Guidelines and Innovative Engineering Boost Appeal of Barrier Isolators

Clearing Regulatory Hurdles

Improving Protein Capture for Transgenic Drug Processing

Related Content

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Aenova Adds Cold Chain Warehouse to Latina, Italy Site

Susan Haigney

June 27th 2025

Article

The new building expands on the company’s supply chain solutions for biologics and temperature-sensitive pharmaceuticals.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas

June 25th 2024

Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

3D Rendering of CAR - Chimeric Antigen Receptor Between T-Cell and Cancer Cell | Image Credit: © Alpha Tauri 3D - stock.adobe.com

Priothera Awarded €1.7M in Innovation Contest for Hematologic Malignancy Treatments

Patrick Lavery

June 26th 2025

Article

The company’s mocravimod, a novel oral S1P receptor, is being evaluated for its efficacy as an addition to CAR-T cell therapies.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol

April 30th 2024

Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.